Replies to post #423451 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

That is a bit misleading since the last annual report was for the year 2020 and we are almost through 2021 and the annual report won't be out for 4 months. The 2021 quarterly filings did not have this language

The 10-K for each of the last 6 years had the statement and none of the 10-Qs did. That this year is exactly like the last 6 does not make for some big news. What is so complicated?

Also, your fast track comment is misleading. Read my prior post about project orbis and starting around p3 topline data availability.

My point about fast track was 100% correct and not misleading.

The fact that NWBO has not yet announced they have for Fast-Track, BreakThrough Designation or RMAT should be a red flag. Why do they not yet have that when all could have been obtained years ago if there is not some undisclosed elephant?

[Gus McCrae]

The 2021 quarterly filings did not have this language.

Haven't you wondered why that fast track language is in all the 10-Ks and not in the 10-Qs? It's pretty easy to figure out...here's a hint, go look at what section in the 10-K your language comes from and then go see if that same section is included in all of the 10-Qs. And by included, I mean, see if all of the other items disclosed under that item in the 2020 Form 10-K are also in the 10-Qs.